Brief: Adaptive Biotechnologies announces plan to separate its MRD and Immune Medicine Businesses
15/06/2026 21:12
June 15 (Reuters) - Adaptive Biotechnologies CorpADPT.O : * ADAPTIVE BIOTECHNOLOGIES ANNOUNCES PLAN TO SEPARATE ITS MRD AND IMMUNE MEDICINE BUSINESSES * ADAPTIVE BIOTECHNOLOGIES - EXPECTS TO IDENTIFY IMMUNE MEDICINE SEPARATION PATH BY YEAR-END 2026 Source text:ID:nGNX9vVtCN Further company coverage:ADPT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates